Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bigger animals have increased cancer risk, study confirms
Elephants' rapid evolution has meant they have managed to reduce their cancer risk.
Findings challenge belief that there is no link with size.

A study has challenged long-standing theories by revealing that larger animals do have an increased risk of developing cancer.

The findings challenge the idea of ‘Peto’s paradox’: a theory from 1977 that suggested that there was no correlation between animal size and cancer risk.

The new study saw researchers from three universities collaborate to examine cancer data from 263 species. This was spread across the four major animal groups: amphibians, birds, mammals and reptiles.

The data had been gathered from veterinary autopsies of 31 amphibians, 79 birds, 90 mammals and 63 reptiles. Using advanced statistical methods, researchers analysed the relationship between cancer rates and body sizes, while taking into account the different species involved.

Researchers discovered that, overall, bigger animals displayed a higher prevalence of benign and malignant tumours.

This finding proved to be consistent in all species, regardless of whether they naturally stop growing (birds and mammals) or grow throughout their lives (amphibians and reptiles).

However, the researchers also identified that rapid evolution was a contributing factor to cancer defence. Animals which have rapidly evolved to a large size over short evolutionary timescales also evolved improved mechanisms to control cell growth and prevent tumours.

This means that, despite being ten times bigger, elephants have approximately the same cancer risk as a tiger.

There were some outliers to the researchers’ theory though, where a subset of species had much more or much less cancer than expected for their body size.

The common budgie, which weighs less than 30g, was found to have cancer rates which were more than 40 times higher than expected for its body size. The naked mole rat, however, had almost no recorded rate of cancer.

Advances in modern medicine means that researchers were unable to apply this theory to humans.

Overall, the research revealed a trend of larger species recording higher cancer rates. However, it also highlighted the role of evolution in developing mechanisms for cellular defence.

George Butler, lead author of the research at University College London, said: “Finding which animals are naturally better at fighting off cancer opens exciting new paths for research.

“By studying these successful species, we can better understand how cancers develop and potentially discover new ways to fight the disease. This could lead to breakthrough treatments in the future."

The full study can be found in the journal Proceedings of the National Academy of Sciences.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."